IL27 and neoplasm: IL-27 is known to induce T cell expression of PD-L1 (Hirahara et al., 2012), and PD-L1-PD-1 interaction among T cells may inhibit T cell effector functions thereby limiting IL-27-mediated anti-tumor efficacy.